Abnormal expression of VEGF and its gene transcription status as diagnostic indicators in patients with non-small cell lung cancer

[1]  R. Cerfolio,et al.  The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy. , 2014, The Annals of thoracic surgery.

[2]  Caicun Zhou,et al.  Prophylactic Cranial Irradiation May Impose a Detrimental Effect on Overall Survival of Patients with Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.

[3]  H. Klomp,et al.  FDG-PET/CT response evaluation during EGFR-TKI treatment in patients with NSCLC. , 2014, World journal of radiology.

[4]  P. Ellis,et al.  The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach , 2014, Front. Oncol..

[5]  M. Lackmann,et al.  Vascular remodeling in cancer , 2014, Oncogene.

[6]  K. O'Byrne,et al.  Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. , 2014, Biochimica et biophysica acta.

[7]  Cizhong Jiang,et al.  Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression. , 2014, Cancer letters.

[8]  S. Akira,et al.  Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  J. Kurie,et al.  Expression of TLR9 in tumor‐infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer , 2014, International journal of cancer.

[10]  R. Rosell,et al.  A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer , 2014, Annals of Surgical Oncology.

[11]  V. Awasthi,et al.  Preclinical evaluation of 4‐[3,5‐bis(2‐chlorobenzylidene)‐4‐oxo‐piperidine‐1‐yl]‐4‐oxo‐2‐butenoic acid, in a mouse model of lung cancer xenograft , 2013, British journal of pharmacology.

[12]  R. Jiang,et al.  Experimental study of Endostar injection concomitant with cryoablation on lung adenocarcinoma A549 xenografts. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[13]  Tiehong Zhang,et al.  A comparison on expression of selected biomarkers between primary lung cancers and matched metastases , 2013, Medical Oncology.

[14]  W. Su,et al.  Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma , 2013, PloS one.

[15]  Kehu Yang,et al.  The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis. , 2013, Swiss medical weekly.

[16]  Keyuan Zhou,et al.  Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1α and VEGF Expression , 2013, Lifestyle Genomics.

[17]  Yingying Wang,et al.  Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression , 2013, PloS one.

[18]  Ping Chen,et al.  Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery. , 2013, Lung cancer.

[19]  Yajuan Chen,et al.  Anti-angiogenic activity of salvicine , 2013, Pharmaceutical biology.

[20]  A. Pries,et al.  Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells. , 2013, Oncology reports.

[21]  Xue Meng,et al.  Serum vascular endothelial growth factor-C levels: A possible diagnostic marker for lymph node metastasis in patients with primary non-small cell lung cancer , 2013, Oncology letters.

[22]  Dong Wang,et al.  Human Apurinic/Apyrimidinic Endonuclease siRNA Inhibits the Angiogenesis Induced by X-Ray Irradiation in Lung Cancer Cells , 2013, International journal of medical sciences.

[23]  Hui Gao,et al.  Digoxin Downregulates NDRG1 and VEGF through the Inhibition of HIF-1α under Hypoxic Conditions in Human Lung Adenocarcinoma A549 Cells , 2013, International journal of molecular sciences.

[24]  Yunmei Yang,et al.  Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549 , 2013, Molecular Biology Reports.

[25]  F. Arias,et al.  Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer , 2009, Cancer.

[26]  Ling-hua Meng,et al.  Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer. , 2014, Cancer letters.

[27]  Ping Chen,et al.  Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis , 2013, Medical Oncology.

[28]  Chih-Teng Yu,et al.  Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer , 2013, Journal of Cancer Research and Clinical Oncology.